• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    market news

    Scientists Developing Cure for Motion Sickness

    Morag Mcgreevey
    Sep. 15, 2015 08:18AM PST
    Medical Device Investing

    Scientists at the Imperial College London are researching a treatment for motion sickness by targeting brain signals found to speed up a person’s ability to adapt to motions.

    Scientists at the Imperial College London are researching a treatment for motion sickness by targeting brain signals found to speed up a person’s ability to adapt to motions.
    According to Reuters:

    Research from Imperial College London, recently published in the scientific journal Neurology, explained how motion sickness occurs when what the eyes see and what the inner ear senses are confused. Clinical scientist Dr Qadeer Arshad hit upon the idea for treating motion sickness when investigating what can influence a person’s sense of balance.
    Most people are prone to a mild queasy feeling at some point, for example on boats or rollercoasters. But around three in ten people suffer from a more severe type of motion sickness, leading to more unpleasant symptoms, such as dizziness, severe nausea and cold sweats.

    Click here to read the entire article on Reuters.


     
    market news
    The Conversation (0)

    Go Deeper

    AI Powered
    Regeneron Pharmaceuticals

    Regeneron Pharmaceuticals

    BlinkLab Limited

    BlinkLab Limited: Transforming Mental Healthcare through Mobile-based AI App

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×